Back to Report Store Home

Global Dermatology Market to 2022 – Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth

  • Published: May-2016
  • Report Code: GBIHC390MR
  • Report Format: pdf

Description

List of Tables

Table 1: Dermatology, Global, Epidemiology of Dermatological Disorders, 2015 15

Table 2: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Humira, 2015 26

Table 3: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Remicade, 2015 27

Table 4: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Enbrel, 2015 29

Table 5: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Stelara, 2015 30

Table 6: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Neoral, 2015 32

Table 7: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Protopic, 2015 33

Table 8: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Elidel, 2015 35

Table 9: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Elocon, 2015 35

Table 10: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Differin, 2015 36

Table 11: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Metolate, 2015 37

Table 12: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Clobex, 2015 38

Table 13: Dermatology Therapeutics Market, Global, Annual Revenue Forecast for Key Products ($bn), 2015–2022 63

Table 14: Dermatology, Global, Usage of Generics Across Key Indications, 2015 65

Table 15: Dermatology Therapeutics Market, Global, Forecast Revenue by Company, 2015–2022 72

Table 16: Dermatology Therapeutics Market, Global, Licensing Deals, 2006–2016 100

Table 17: Dermatology Therapeutics Market, Global, Co-development Deals, 2006–2016 105

Table 18: Epidemiology Patterns for Atopic Dermatitis, 2015–2022 111

Table 19: Epidemiology Patterns for Acne Vulgaris, 2015–2022 111

Table 20: Epidemiology Patterns for Psoriasis, 2015–2022 111

Table 21: Dermatology, Global, Table of all Clinical Stage Pipeline Products, 2016 112

Table 22: Abbreviations 144

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards